By expenditures
| Name | Title | Type |
|---|---|---|
| Lisa Horn | Partner | Auditee |
| Christopher Telli | Partner | Auditee |
| Tanya Middlemist | Sr. Financial Analyst | Auditee |
| Chris Telli | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 363015 | 2024 | 2025-07-25 | Forvis Mazars LLP | $145.52M |
| 316407 | 2023 | 2024-07-31 | Forvis Mazars LLP | $105.91M |
| 22844 | 2022 | 2023-09-28 | Forvis LLP | $86.37M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 363015 | 2024 | 2025-07-25 | 1148370 | 2024-001 | Significant Deficiency | - | ABE |
| 363015 | 2024 | 2025-07-25 | 571928 | 2024-001 | Significant Deficiency | - | ABE |
| 316407 | 2023 | 2024-07-31 | 1056541 | 2023-004 | Significant Deficiency | - | M |
| 316407 | 2023 | 2024-07-31 | 480099 | 2023-004 | Significant Deficiency | - | M |
| 22844 | 2022 | 2023-09-28 | 596903 | 2022-005 | Material Weakness | Yes | E |
| 22844 | 2022 | 2023-09-28 | 596902 | 2022-005 | Material Weakness | Yes | E |
| 22844 | 2022 | 2023-09-28 | 596901 | 2022-006 | Significant Deficiency | - | E |
| 22844 | 2022 | 2023-09-28 | 20461 | 2022-005 | Material Weakness | Yes | E |
| 22844 | 2022 | 2023-09-28 | 20460 | 2022-005 | Material Weakness | Yes | E |
| 22844 | 2022 | 2023-09-28 | 20459 | 2022-006 | Significant Deficiency | - | E |